Thursday, August 31, 2017

Viridian to Host #Cannabis #Investor Workshop at MJAC 2017 InvestorsHub International Cannabis Conference

Viridian to Host #Cannabis #Investor Workshop at MJAC 2017 InvestorsHub International Cannabis Conference

New York, N.Y. - August 31, 2017 (Investorideas.com Newswire) Viridian Capital Advisors will host a 2-hour cannabis investment workshop at the upcoming MJAC 2017 InvestorsHub International Cannabis Conference in Los Angeles this Saturday, September 2nd at the JW Marriott L.A. from 12pm - 2:15pm PDT.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


EnWave (TSX VENTURE: $ENW.V) Files New Patent Application on Methods for Rapidly Drying and Decontaminating #Cannabis

EnWave (TSX VENTURE: $ENW.V) Files New Patent Application on Methods for Rapidly Drying and Decontaminating #Cannabis

VANCOUVER, BC - August 30, 2017 (Investorideas.com Newswire) EnWave Corporation (TSX VENTURE: ENW) (FRANKFURT: E4U) ("EnWave", or the "Company") reports today the submission of a new patent application in the Patent Cooperation Treaty ("PCT") international patent system. EnWave is driven to innovate and continuously commits resources to strengthen its intellectual property portfolio which is the cornerstone for the Company's licensing-royalty business model. This patent application expands the application of EnWave's Radiant Energy Vacuum ("REV™") technology to the rapidly growing global medicinal and recreational cannabis market sector.

The newly filed patent application claims methods for very rapid and simultaneous pasteurization and drying of cannabis using REV™ technology.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Wednesday, August 30, 2017

Today's Viridian #Cannabis Deal Tracker for Week Ended August 25, 2017

Today's Viridian #Cannabis Deal Tracker for Week Ended August 25, 2017

Viridian Capital Advisors (www.viridianca.com)

August 30, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian Activity in the Cannabis Industry for the week ending August 25, 2017.





Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing



Watch the 420 Cannabis Investor video

 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Quadron (CSE:QCC) (CSE:QCC.CN) (CNSX:QCC) Reports Annual Results for the Year Ended April 30, 2017

Quadron (CSE:QCC) (CSE:QCC.CN) (CNSX:QCC) Reports Annual Results for the Year Ended April 30, 2017

VANCOUVER, BRITISH COLUMBIA - August 30, 2017 (Investorideas.com Newswire) Quadron Cannatech Corporation (the "Company" or "Quadron") (CSE:QCC)(CSE:QCC.CN)(CNSX:QCC) is pleased to report the annual financial and operating results for the year ended April 30, 2017.




Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing



Watch the 420 Cannabis Investor video

 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Scythian Biosciences Corp. (TSXV: $SCYB.V) Applies for Listing of Common Stock on NASDAQ

Scythian Biosciences Corp. (TSXV: $SCYB.V) Applies for Listing of Common Stock on NASDAQ



TORONTO - August 30, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (TSXV: SCYB) (the "Company") is pleased to announce that it has submitted an initial listing application to list its common shares on the NASDAQ Capital Market.

The Company's common shares have traded on the TSX Venture Exchange (the "TSXV") under the symbol "SCYB" since August 8, 2017.


Scythian Biosciences Corp. (TSX.V: SCYB)
is a Featured biotech and marijuana company on Investorideas.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Tuesday, August 29, 2017

#Cannabis News: Pharmacist Launches New #CBD Company, Honest Herbal, and Takes Top Honors in DOPE Magazine Competition

#Cannabis News: Pharmacist Launches New #CBD Company, Honest Herbal, and Takes Top Honors in DOPE Magazine Competition

DENVER - August 29, 2017 (Investorideas.com Newswire) Kristy Redmon, Honest Herbal president, founder and a registered pharmacist, announced that the company is the recipient of two awards in DOPE Magazine's DOPE Cup Colorado. The full-spectrum CBD hemp company placed first in the Best CBD Edible category for its capsules and took second place for Best Transdermal Cream.





Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video

 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Concussion and TBI Treatment Company Scythian Biosciences (TSX.V: $SCYB.V) Retains The Weinberg Group for FDA IND and IND Consulting Services

Concussion and TBI Treatment Company Scythian Biosciences (TSX.V: $SCYB.V) Retains The Weinberg Group for FDA IND and IND Consulting Services



TORONTO - August 29, 2017 (Investorideas.com Newswire)   FDA news - Scythian Biosciences Corp. (the "Company") (TSXV: SCYB) reports  it has entered into a consulting arrangement with The Weinberg Group and has retained The Weinberg Group's services for assistance with the Company's FDA application process, including pre-IND and IND consulting services.

Read this news in full at

Scythian Biosciences Corp. (TSX.V: SCYB)
is a Featured biotech and marijuana company on Investorideas.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp

Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Monday, August 28, 2017

Friday Night Inc. (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) Enters into a Land Purchase Agreement

Friday Night Inc. (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) Enters into a Land Purchase Agreement

Vancouver, British Columbia - August 28, 2017 (Investorideas.com Newswire) Friday Night Inc. (Friday Night) (CSE: TGIF) (FWB: 1QF) (OTC: VPGDF) is pleased to announce that it has entered into a land purchase agreement in Nevada.

Friday Night Inc. has entered into an agreement to purchase 1.39 acres of land in unincorporated Clark County for $432,000 (USD). The parcel is zoned M-1 and includes several site improvements including a 33,000-sq. ft. footprint for a building with footings already poured and in the ground, full perimeter security fences, water hook-ups for the full sprinkler system throughout the future warehouse and 2,000 amps of power. In addition, the Company has now secured an estimate from NV Energy to provide an additional 4,000 amps of power, which would support a two-story cultivation of up to 66,000 sq. ft. of canopy. All documents have been signed and the escrow has been opened with a $25,000 (USD) earnest money deposit. The terms provide for a closing within 85 days or sooner. Plans are being reviewed and revised for an updated cost estimate, which will be ready within 2 weeks.






Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Scythian Biosciences Corp. (TSX.V: $SCYB.V) Retains The Weinberg Group To Provide FDA Consulting Services

Scythian Biosciences Corp. (TSX.V: $SCYB.V) Retains The Weinberg Group To Provide FDA Consulting Services



TORONTO - August 28, 2017 (Investorideas.com Newswire) Scythian Biosciences Corp. (the "Company") (
TSXV: SCYB) is pleased to announce that it has entered into a consulting arrangement with The Weinberg Group and has retained The Weinberg Group's services for assistance with the Company's FDA application process, including pre-IND and IND consulting services.

Read this news in full at

About Scythian Biosciences Corp.
Scythian is a research and development company committed to finding a solution for the prevention and treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination.

Scythian Biosciences Corp. (TSX.V: SCYB)
is a Featured biotech and marijuana company on Investorideas.com


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Scythian Biosciences Corp. (SCYB) is a paid featured company on the 420 Cannabis Investor Ideas Directory and is a paid featured cannabis company and biotech for news, social media and PR effective August 7th for 2 months. More details - http://www.investorideas.com/About/News/Clientspecifics.asp


Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country

Friday, August 25, 2017

Today's Viridian #Cannabis Deal Tracker for Week Ended August 18, 2017

Today's Viridian #Cannabis Deal Tracker for Week Ended August 18, 2017

Viridian Capital Advisors (www.viridianca.com)

August 25, 2017 (Investorideas.com Newswire) Viridian Capital Advisors, LLC reports on its weekly Viridian Activity in the Cannabis Industry for the week ending August 18, 2017.

Read this news in full at




Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Merry Jane, The First Cannabis Brand To Receive Emmy Nomination, Continues To Dominate With Original Content

Merry Jane, The First Cannabis Brand To Receive Emmy Nomination, Continues To Dominate With Original Content

Cannabis News and Lifestyle Media Platform Increases Global Growth With Exclusive Content Featuring Floyd Mayweather; And New Shows Produced By Wiz Khalifa & Taylor Gang and Seth Rogen & Point Grey

LOS ANGELES - August 25, 2017 (Investorideas.com Newswire) With an impressive 2017 underway, MERRY JANE has become the fastest-growing and most widely-accepted cannabis news and lifestyle media platform through the creation of strategic partnerships with major studios, networks, record labels and brands. The platform continues to push boundaries, producing innovative content with top entertainers, setting the stage for MERRY JANE to receive the industry's first-ever Emmy nomination for VH1's "Martha & Snoop's Potluck Dinner Party."

Production partners VH1 Network, MERRY JANE, Sequential Brands Group and 495 Productions made history with the wildly-popular "Martha & Snoop's Potluck Dinner Party" being nominated for a 2017 Emmy award in the "Host for a Reality/Reality-Competition Program" category, which will be announced in September. The nomination comes as the beloved cooking show returns to VH1 this fall for a star-studded second season, with guests including: P. Diddy, Jamie Foxx, Usher, Patti Labelle, LL Cool J, Queen Latifah, Don Cheadle, Kate Upton, Terrence Howard, Anthony Anderson and more.

Read this news in full at




Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory


Watch the 420 Cannabis Investor video


 


This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.